{
 "as_of": {
  "fda_ashp_checked": "2026-10-20",
  "simtriyo_checked": "2026-11-04",
  "rechecked_2026_10_29": [
   "daytrana",
   "adderall",
   "ritalin-la",
   "aptensio-xr",
   "quillivant-xr"
  ],
  "orange_book": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
  "page_built": "2026-10-29"
 },
 "note": "Curated FDA Drug Shortages / ASHP fields paraphrased from checks dated on each row; Orange Book fields read from the FDA data file. RX in the Orange Book means approved and not listed as discontinued; it does not confirm pharmacy stock.",
 "products": {
  "concerta": {
   "name": "Concerta",
   "page": "https://adhdmedications.com/concerta.html",
   "site_status": "ER TABLET SHORTAGE · BRAND AVAILABLE",
   "fda_drug_shortages": {
    "text": "Methylphenidate ER tablets currently in shortage (first posted Jul 26, 2023); Janssen lists Concerta 18–54 mg Available (reverified Sep 17, 2026); some generic makers limited or unavailable",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet%2C%20Extended%20Release&st=c"
   },
   "ashp": {
    "text": "Concerta available",
    "as_of": "updated Oct 14, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021121",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Actavis Laboratories FL Inc",
      "AB"
     ],
     [
      "Alkem Laboratories Ltd",
      "AB"
     ],
     [
      "Andor Pharmaceuticals LLC",
      "AB"
     ],
     [
      "Ascent Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Aurolife Pharma LLC",
      "AB"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Osmotica Pharmaceutical US LLC",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021121"
   },
   "other": [],
   "disagreement": null
  },
  "focalin-xr": {
   "name": "Focalin XR",
   "page": "https://adhdmedications.com/focalin-xr.html",
   "site_status": "PARTIAL SHORTAGE (ASHP)",
   "fda_drug_shortages": {
    "text": "No dexmethylphenidate entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand 5 mg (intermittent) and 35 mg on back order; other brand strengths and several generics available; some generics on back order",
    "as_of": "updated Oct 15, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=955"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021802",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Adare Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Ascent Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Impax Laboratories Inc",
      "AB"
     ],
     [
      "PH Health Ltd",
      "AB"
     ],
     [
      "Platinum Pharmaceuticals",
      "AB"
     ],
     [
      "Teva Pharmaceuticals USA",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021802"
   },
   "other": [
    {
     "text": "DailyMed lists 2026 marketing end dates for the Novartis-labeled brand NDCs; Sandoz-labeled NDCs have none",
     "as_of": "Oct 20, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9cf76f62-48aa-4065-94fd-6fc910391ab5"
    }
   ],
   "disagreement": null
  },
  "jornay-pm": {
   "name": "Jornay PM",
   "page": "https://adhdmedications.com/jornay-pm.html",
   "site_status": "AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No methylphenidate ER capsule entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Available, 20–100 mg",
    "as_of": "updated Oct 14, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 209311",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=209311"
   },
   "other": [],
   "disagreement": null
  },
  "ritalin-la": {
   "name": "Ritalin LA",
   "page": "https://adhdmedications.com/ritalin-la.html",
   "site_status": "SOURCES DIFFER ON BRAND STATUS",
   "fda_drug_shortages": {
    "text": "No methylphenidate ER capsule entry",
    "as_of": "checked Oct 29, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand bottles discontinued; Sandoz authorized generic available; Teva LA capsules temporarily unavailable",
    "as_of": "updated Oct 14, 2026; checked Oct 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "mixed: 4 strength(s) RX, 1 DISCN",
    "application": "NDA 021284",
    "te": [
     "AB1"
    ],
    "generics_rx": [
     [
      "Dr Reddys Laboratories SA",
      "AB1"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AB1"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021284"
   },
   "other": [
    {
     "text": "DailyMed: brand marketing end dates of Sep 30, 2026 (10 and 30 mg) and Oct 31, 2026 (20 and 40 mg)",
     "as_of": "Oct 29, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=effd952d-ac94-47bb-b107-589a4934dcca"
    },
    {
     "text": "Orange Book web search: Ritalin LA 10–40 mg RX/AB1; 60 mg DISCN",
     "as_of": "Oct 29, 2026",
     "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021284"
    }
   ],
   "disagreement": "DailyMed lists brand marketing end dates in Sep–Oct 2026 and ASHP lists the brand bottles as discontinued, while the Orange Book still lists four Ritalin LA strengths as RX. Rechecked Oct 29, 2026."
  },
  "aptensio-xr": {
   "name": "Aptensio XR",
   "page": "https://adhdmedications.com/aptensio-xr.html",
   "site_status": "SOURCES DIFFER ON BRAND STATUS",
   "fda_drug_shortages": {
    "text": "No methylphenidate ER capsule entry",
    "as_of": "checked Oct 29, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand and Rhodes authorized generic on back order (no reason or release estimate given); Teva AB3 generic listed as affected, status not stated",
    "as_of": "updated Oct 14, 2026; checked Oct 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 205831",
    "te": [
     "AB3"
    ],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB3"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=205831"
   },
   "other": [
    {
     "text": "DailyMed: the Aptensio XR label lists marketing end dates of May 20, 2026 for all brand NDCs; it no longer appears in DailyMed search results",
     "as_of": "Oct 29, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5adedc01-ebf0-11e3-ac10-0800200c9a66"
    },
    {
     "text": "Orange Book web search: Aptensio XR NDA 205831, all seven strengths RX/AB3",
     "as_of": "Oct 29, 2026",
     "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=205831"
    }
   ],
   "disagreement": "DailyMed shows brand marketing end dates of May 20, 2026 (and the label no longer appears in DailyMed search) and ASHP lists back orders, while the Orange Book lists all seven Aptensio XR strengths as RX. Rechecked Oct 29, 2026."
  },
  "quillivant-xr": {
   "name": "Quillivant XR",
   "page": "https://adhdmedications.com/quillivant-xr.html",
   "site_status": "AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No methylphenidate suspension entry",
    "as_of": "checked Oct 29, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Available, all bottle sizes; no generic suspension listed",
    "as_of": "updated Oct 14, 2026; checked Oct 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 202100",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Actavis Laboratories FL Inc",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=202100"
   },
   "other": [
    {
     "text": "FDA NDC Directory (openFDA data updated Oct 28, 2026) and DailyMed: no product listed under ANDA 206049; only the four Quillivant XR NDCs",
     "as_of": "Oct 29, 2026",
     "url": "https://www.accessdata.fda.gov/scripts/cder/ndc/index.cfm"
    },
    {
     "text": "Orange Book web search: ANDA 206049 (Actavis Labs FL) RX/AB, approved May 17, 2018",
     "as_of": "Oct 29, 2026",
     "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=206049"
    }
   ],
   "disagreement": "The Orange Book lists one AB-rated generic (Actavis, ANDA 206049) as RX, while the FDA NDC Directory and DailyMed list no product under that application and ASHP lists only the brand. Rechecked Oct 29, 2026."
  },
  "cotempla-xr-odt": {
   "name": "Cotempla XR-ODT",
   "page": "https://adhdmedications.com/cotempla-xr-odt.html",
   "site_status": "AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No methylphenidate ODT entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand (Aytu) and authorized generic (Neos) available",
    "as_of": "updated Oct 14, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "mixed: 3 strength(s) RX, 1 DISCN",
    "application": "NDA 205489",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=205489"
   },
   "other": [],
   "disagreement": null
  },
  "azstarys": {
   "name": "Azstarys",
   "page": "https://adhdmedications.com/azstarys.html",
   "site_status": "MARKETED",
   "fda_drug_shortages": {
    "text": "No entry for this product",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 212994",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=212994"
   },
   "other": [],
   "disagreement": null
  },
  "daytrana": {
   "name": "Daytrana",
   "page": "https://adhdmedications.com/daytrana.html",
   "site_status": "SOURCES DIFFER ON BRAND STATUS",
   "fda_drug_shortages": {
    "text": "Methylphenidate ER film in shortage (first posted Feb 28, 2025); only Noven’s patches distributed by Padagis (authorized-generic NDCs 0574-2410 to -2430) are listed, all four strengths Available; brand Daytrana NDCs are not listed",
    "as_of": "Noven reverified Oct 16, 2026; checked Oct 29, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Film%2C%20Extended%20Release&st=c"
   },
   "ashp": {
    "text": "Noven discontinued Daytrana in early 2026; Mylan (Viatris) and Padagis (authorized generic) patches available; bulletin not on the current-shortages list",
    "as_of": "updated Mar 19, 2026; checked Oct 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=1138"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021514",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Mylan Technologies Inc A Viatris Co",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021514"
   },
   "other": [
    {
     "text": "DailyMed: the Daytrana label (Noven, SPL version 29) lists all four NDCs as marketed with no end date",
     "as_of": "Oct 29, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c312c31-3198-4775-91ab-294e0b4b9e7f"
    },
    {
     "text": "DailyMed: Mylan’s generic patch label lists marketing end dates of Jan 31, 2027 (30 mg) and Apr 30, 2027 (10, 15, 20 mg)",
     "as_of": "Oct 29, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1643b6a5-80da-4d4f-8c5f-feb907875702"
    },
    {
     "text": "Orange Book web search: Daytrana NDA 021514 RX/AB (all four strengths); Mylan ANDA 206497 RX/AB",
     "as_of": "Oct 29, 2026",
     "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021514"
    }
   ],
   "disagreement": "ASHP reports that brand Daytrana was discontinued in early 2026, while the Orange Book lists Daytrana as RX and DailyMed lists all four Daytrana NDCs as marketed with no end date. The FDA shortage entry lists only the Padagis-distributed patches (Available). Rechecked Oct 29, 2026."
  },
  "ritalin": {
   "name": "Ritalin",
   "page": "https://adhdmedications.com/ritalin.html",
   "site_status": "BRAND AVAILABLE",
   "fda_drug_shortages": {
    "text": "No methylphenidate immediate-release tablet entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand Ritalin available; some generics on back order or discontinued",
    "as_of": "updated Oct 15, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=973"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 010187",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Abhai LLC",
      "AB"
     ],
     [
      "Accord Healthcare Inc",
      "AB"
     ],
     [
      "Alkem Laboratories Ltd",
      "AB"
     ],
     [
      "Ascent Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Bionpharma Inc",
      "AB"
     ],
     [
      "Cediprof Inc",
      "AB"
     ],
     [
      "Mpp Pharma LLC",
      "AB"
     ],
     [
      "Novel Laboratories Inc",
      "AB"
     ],
     [
      "Oxford Pharmaceuticals LLC",
      "AB"
     ],
     [
      "Prinston Pharmaceutical Inc",
      "AB"
     ],
     [
      "SpecGx LLC",
      "AB"
     ],
     [
      "Sun Pharmaceutical Industries Inc",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=010187"
   },
   "other": [],
   "disagreement": null
  },
  "adhansia-xr": {
   "name": "Adhansia XR",
   "page": "https://adhdmedications.com/adhansia-xr.html",
   "site_status": "DISCONTINUED",
   "fda_drug_shortages": {
    "text": "No entry for this product",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "DISCN (discontinued)",
    "application": "NDA 212038",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=212038"
   },
   "other": [
    {
     "text": "DailyMed label (revised 06/2021) lists marketing end dates in 2023",
     "as_of": "Oct 20, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80e15bd0-4d56-75f0-ab5a-885879fc56e9"
    }
   ],
   "disagreement": null
  },
  "quillichew-er": {
   "name": "QuilliChew ER",
   "page": "https://adhdmedications.com/quillichew-er.html",
   "site_status": "AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No chewable methylphenidate entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Available, 20–40 mg",
    "as_of": "updated Oct 14, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 207960",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=207960"
   },
   "other": [],
   "disagreement": null
  },
  "focalin": {
   "name": "Focalin",
   "page": "https://adhdmedications.com/focalin.html",
   "site_status": "BRAND MARKETED · END DATES 2027",
   "fda_drug_shortages": {
    "text": "No dexmethylphenidate immediate-release entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021278",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Abhai LLC",
      "AB"
     ],
     [
      "Alkem Laboratories Ltd",
      "AB"
     ],
     [
      "Cediprof Inc",
      "AB"
     ],
     [
      "Novel Laboratories Inc",
      "AB"
     ],
     [
      "Sun Pharmaceutical Industries Inc",
      "AB"
     ],
     [
      "Tris Pharma Inc",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021278"
   },
   "other": [
    {
     "text": "DailyMed (Sandoz) lists planned marketing end dates in 2027 for all three brand strengths",
     "as_of": "Oct 20, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2016f5c2-95d2-4655-af65-c588c2bf5e6d"
    }
   ],
   "disagreement": "DailyMed lists planned 2027 marketing end dates for brand Focalin; the Orange Book still lists it as RX. These do not conflict yet, but the brand may leave the market in 2027."
  },
  "relexxii": {
   "name": "Relexxii",
   "page": "https://adhdmedications.com/relexxii.html",
   "site_status": "AVAILABLE (FDA LISTING)",
   "fda_drug_shortages": {
    "text": "Methylphenidate ER tablets in shortage, but Vertical lists Relexxii 18–72 mg Available",
    "as_of": "reverified Oct 16, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet%2C%20Extended%20Release&st=c"
   },
   "ashp": {
    "text": "Relexxii 18–72 mg available",
    "as_of": "updated Oct 14, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 216117",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=216117"
   },
   "other": [],
   "disagreement": null
  },
  "metadate-cd": {
   "name": "Metadate CD",
   "page": "https://adhdmedications.com/metadate-cd.html",
   "site_status": "AYTU BRAND DISCONTINUED · NOW LANNETT",
   "fda_drug_shortages": {
    "text": "No methylphenidate ER capsule entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Aytu-marketed Metadate CD discontinued; Lannett methylphenidate CD capsules available; Amneal on back order",
    "as_of": "updated Oct 14, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021259",
    "te": [
     "AB2"
    ],
    "generics_rx": [
     [
      "Impax Laboratories Inc",
      "AB2"
     ],
     [
      "SpecGx LLC",
      "AB2"
     ],
     [
      "Teva Pharmaceuticals USA",
      "AB2"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021259"
   },
   "other": [
    {
     "text": "Lannett's Metadate CD label (revised 10/2026) is on DailyMed",
     "as_of": "Oct 20, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29f06562-6b6a-4ca6-b62e-d08a45fb3dd4"
    }
   ],
   "disagreement": "ASHP lists Metadate CD as discontinued (Aytu), while Lannett now holds the brand with current labeling and the Orange Book lists it as RX. These refer to different companies' products."
  },
  "methylin": {
   "name": "Methylin",
   "page": "https://adhdmedications.com/methylin.html",
   "site_status": "MARKETED (ORAL SOLUTION)",
   "fda_drug_shortages": {
    "text": "No methylphenidate oral solution entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021419",
    "te": [
     "AA"
    ],
    "generics_rx": [
     [
      "Abhai LLC",
      "AA"
     ],
     [
      "Adaptis Pharma Private Ltd",
      "AA"
     ],
     [
      "Alkem Laboratories Ltd",
      "AA"
     ],
     [
      "Anda Repository LLC",
      "AA"
     ],
     [
      "Ascent Pharmaceuticals Inc",
      "AA"
     ],
     [
      "Novel Laboratories Inc",
      "AA"
     ],
     [
      "Quagen Pharmaceuticals LLC",
      "AA"
     ],
     [
      "Tris Pharma Inc",
      "AA"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021419"
   },
   "other": [
    {
     "text": "Retail stock of the brand liquid not confirmed",
     "as_of": "Oct 20, 2026",
     "url": null
    }
   ],
   "disagreement": null
  },
  "methylphenidate-er-tablets": {
   "name": "Methylphenidate ER (10/20 mg)",
   "page": "https://adhdmedications.com/methylphenidate-er-tablets.html",
   "site_status": "RITALIN-SR BRAND DISCONTINUED",
   "fda_drug_shortages": {
    "text": "The methylphenidate ER tablet shortage entry lists only 18–72 mg presentations, none at 10 or 20 mg",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Methylphenidate%20Hydrochloride%20Tablet%2C%20Extended%20Release&st=c"
   },
   "ashp": {
    "text": "KVK-Tech 10 and 20 mg available; Mallinckrodt (SpecGx) 10 and 20 mg on back order",
    "as_of": "updated Oct 14, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=896"
   },
   "orange_book": {
    "brand": "DISCN (discontinued)",
    "application": "NDA 018029",
    "te": [],
    "generics_rx": [
     [
      "Abhai LLC",
      "AB"
     ],
     [
      "Alkem Laboratories Ltd",
      "AB"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AB"
     ],
     [
      "SpecGx LLC",
      "AB"
     ]
    ],
    "note": "Brand shown: Ritalin-SR (the reference product).",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=018029"
   },
   "other": [],
   "disagreement": null
  },
  "methylphenidate-chewable-tablets": {
   "name": "Methylphenidate Chewable",
   "page": "https://adhdmedications.com/methylphenidate-chewable-tablets.html",
   "site_status": "METHYLIN CHEWABLE BRAND DISCONTINUED",
   "fda_drug_shortages": {
    "text": "No methylphenidate chewable entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not covered (the immediate-release bulletin lists no chewable products)",
    "as_of": "Oct 15, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=973"
   },
   "orange_book": {
    "brand": "DISCN (discontinued)",
    "application": "NDA 021475",
    "te": [],
    "generics_rx": [
     [
      "Ascent Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Rising Pharma Holdings Inc",
      "AB"
     ]
    ],
    "note": "Brand shown: Methylin chewable tablets (the reference product).",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021475"
   },
   "other": [
    {
     "text": "DailyMed lists generic chewable tablets as marketed by Rising and by labelers of the Ascent product",
     "as_of": "Oct 20, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5cb0740-813f-4dce-8c29-d7680c66e77c"
    }
   ],
   "disagreement": null
  },
  "vyvanse": {
   "name": "Vyvanse",
   "page": "https://adhdmedications.com/vyvanse.html",
   "site_status": "FDA SHORTAGE LISTED · BRAND AVAILABLE",
   "fda_drug_shortages": {
    "text": "Lisdexamfetamine capsules and chewable tablets currently in shortage (first posted Jul 14, 2023); Takeda lists Vyvanse capsules 10–70 mg Available",
    "as_of": "Takeda reverified Oct 15, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Capsule&st=c"
   },
   "ashp": {
    "text": "Vyvanse available; Apotex, Hikma, Solco and Sun limited",
    "as_of": "updated Aug 28, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=961"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021977",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB"
     ],
     [
      "Alkem Laboratories Ltd",
      "AB"
     ],
     [
      "Amneal Pharmaceuticals LLC",
      "AB"
     ],
     [
      "Apotex Inc",
      "AB"
     ],
     [
      "Ascent Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Elite Laboratories Inc",
      "AB"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Hikma Pharmaceuticals USA Inc",
      "AB"
     ],
     [
      "Lannett Co Inc",
      "AB"
     ],
     [
      "MSN Laboratories Private Ltd",
      "AB"
     ],
     [
      "Mylan Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Norwich Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Prinston Pharmaceutical Inc",
      "AB"
     ],
     [
      "Rhodes Pharmaceuticals LP",
      "AB"
     ],
     [
      "Sandoz Inc",
      "AB"
     ],
     [
      "SpecGx LLC",
      "AB"
     ],
     [
      "Sun Pharmaceutical Industries Inc",
      "AB"
     ],
     [
      "Teva Pharmaceuticals Development Inc",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021977"
   },
   "other": [
    {
     "text": "FDA chewable-tablet listing",
     "as_of": "Oct 20, 2026",
     "url": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Lisdexamfetamine%20Dimesylate%20Tablet%2C%20Chewable&st=c"
    }
   ],
   "disagreement": null
  },
  "adderall-xr": {
   "name": "Adderall XR",
   "page": "https://adhdmedications.com/adderall-xr.html",
   "site_status": "BRAND AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No entry for extended-release mixed amphetamine salts capsules",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand available in all strengths; several generics on back order or allocation (Teva: increased demand)",
    "as_of": "updated Sep 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=863"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 021303",
    "te": [
     "AB1"
    ],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB1"
     ],
     [
      "Ani Pharmaceuticals Inc",
      "AB1"
     ],
     [
      "Ascent Pharmaceuticals Inc",
      "AB1"
     ],
     [
      "Elite Laboratories Inc",
      "AB1"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AB1"
     ],
     [
      "Impax Laboratories Inc",
      "AB1"
     ],
     [
      "Lannett Co Inc",
      "AB1"
     ],
     [
      "Lupin Inc",
      "AB1"
     ],
     [
      "Rhodes Pharmaceuticals LP",
      "AB1"
     ],
     [
      "SpecGx LLC",
      "AB1"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021303"
   },
   "other": [],
   "disagreement": null
  },
  "xelstrym": {
   "name": "Xelstrym",
   "page": "https://adhdmedications.com/xelstrym.html",
   "site_status": "SUPPLY DISRUPTION (NOVEN / ASHP)",
   "fda_drug_shortages": {
    "text": "No Xelstrym entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Dextroamphetamine Transdermal System listed as a current shortage (created Oct 1, 2026; detail page could not be retrieved)",
    "as_of": "Oct 1, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 215401",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=215401"
   },
   "other": [
    {
     "text": "Noven announced a supply disruption affecting all strengths (active-ingredient shortage) on Jun 1, 2026",
     "as_of": "Jun 1, 2026",
     "url": "https://www.noven.com/wp-content/uploads/2026/06/PR060126B.pdf"
    }
   ],
   "disagreement": null
  },
  "adderall": {
   "name": "Adderall",
   "page": "https://adhdmedications.com/adderall.html",
   "site_status": "SHORTAGE LISTED · SOURCES DIFFER ON BRAND STATUS",
   "fda_drug_shortages": {
    "text": "Currently in shortage (first posted Oct 12, 2022); Teva lists brand 5, 7.5, 10, 15, 20 and 30 mg Available and 12.5 mg Unavailable (recovery estimated November 2026)",
    "as_of": "Teva reverified Oct 15, 2026; checked Oct 29, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Amphetamine%20Aspartate%20Monohydrate%2C%20Amphetamine%20Sulfate%2C%20Dextroamphetamine%20Saccharate%2C%20Dextroamphetamine%20Sulfate%20Tablet&st=c"
   },
   "ashp": {
    "text": "Brand 12.5 mg on back order (release estimated November 2026), other brand strengths available; Teva generic 30 mg limited; several generic makers limited or on back order",
    "as_of": "updated Oct 27, 2026; checked Oct 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=857"
   },
   "orange_book": {
    "brand": "DISCN (discontinued)",
    "application": "NDA 011522",
    "te": [],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB"
     ],
     [
      "Alkem Laboratories Ltd",
      "AB"
     ],
     [
      "Alvogen Inc",
      "AB"
     ],
     [
      "Ascent Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Aurolife Pharma LLC",
      "AB"
     ],
     [
      "Barr Laboratories Inc",
      "AB"
     ],
     [
      "Cediprof Inc",
      "AB"
     ],
     [
      "Elite Laboratories Inc",
      "AB"
     ],
     [
      "Epic Pharma LLC",
      "AB"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Lannett Co Inc",
      "AB"
     ],
     [
      "Nuvo Pharmaceutical Inc",
      "AB"
     ],
     [
      "Pharmobedient Consulting LLC",
      "AB"
     ],
     [
      "Rhodes Pharmaceuticals LP",
      "AB"
     ],
     [
      "Sandoz Inc",
      "AB"
     ],
     [
      "SpecGx LLC",
      "AB"
     ],
     [
      "Sun Pharmaceutical Industries Inc",
      "AB"
     ],
     [
      "Zydus Pharmaceuticals USA Inc",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=011522"
   },
   "other": [
    {
     "text": "DailyMed: Teva’s Adderall label names ANDA 040422 and lists all seven NDCs as marketed with no end date",
     "as_of": "Oct 29, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f22635fe-821d-4cde-aa12-419f8b53db81"
    },
    {
     "text": "Orange Book web search: NDA 011522 (Adderall) DISCN; ANDA 040422 (Barr Laboratories) RX/AB",
     "as_of": "Oct 29, 2026",
     "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=040422"
    }
   ],
   "disagreement": "The Orange Book lists the original brand Adderall application (NDA 011522) as discontinued, while DailyMed lists Teva’s Adderall as marketed under ANDA 040422 (RX in the Orange Book) and the FDA and ASHP shortage pages list most brand strengths as available. Rechecked Oct 29, 2026."
  },
  "mydayis": {
   "name": "Mydayis",
   "page": "https://adhdmedications.com/mydayis.html",
   "site_status": "BRAND AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No entry for this product",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand available in all strengths",
    "as_of": "updated Sep 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=863"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 022063",
    "te": [
     "AB2"
    ],
    "generics_rx": [
     [
      "SpecGx LLC",
      "AB2"
     ],
     [
      "Sun Pharmaceutical Industries Inc",
      "AB2"
     ],
     [
      "Teva Pharmaceuticals USA Inc",
      "AB2"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=022063"
   },
   "other": [],
   "disagreement": null
  },
  "adzenys-xr-odt": {
   "name": "Adzenys XR-ODT",
   "page": "https://adhdmedications.com/adzenys-xr-odt.html",
   "site_status": "AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No entry for this product",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Brand (Aytu) and authorized generic (Neos) available",
    "as_of": "updated Sep 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=863"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 204326",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Actavis Laboratories FL Inc",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=204326"
   },
   "other": [],
   "disagreement": null
  },
  "dyanavel-xr": {
   "name": "Dyanavel XR",
   "page": "https://adhdmedications.com/dyanavel-xr.html",
   "site_status": "AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No entry for this product",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Tablets and suspension available",
    "as_of": "updated Sep 29, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=863"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 208147",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=208147"
   },
   "other": [],
   "disagreement": null
  },
  "evekeo": {
   "name": "Evekeo",
   "page": "https://adhdmedications.com/evekeo.html",
   "site_status": "MARKETED",
   "fda_drug_shortages": {
    "text": "No amphetamine sulfate tablet entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "ANDA 200166",
    "te": [
     "AA"
    ],
    "generics_rx": [
     [
      "Alkem Laboratories Ltd",
      "AA"
     ],
     [
      "Amneal Pharmaceuticals Of New York LLC",
      "AA"
     ],
     [
      "Aurolife Pharma LLC",
      "AA"
     ],
     [
      "Bionpharma Inc",
      "AA"
     ],
     [
      "Epic Pharma LLC",
      "AA"
     ],
     [
      "Granules Pharmaceuticals Inc",
      "AA"
     ],
     [
      "Pharmazone",
      "AA"
     ],
     [
      "Prinston Pharmaceutical Inc",
      "AA"
     ],
     [
      "SpecGx LLC",
      "AA"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=200166"
   },
   "other": [],
   "disagreement": null
  },
  "arynta": {
   "name": "Arynta",
   "page": "https://adhdmedications.com/arynta.html",
   "site_status": "MARKETED (SPL 03/2026)",
   "fda_drug_shortages": {
    "text": "No Arynta-specific entry (the lisdexamfetamine entries cover capsules and chewable tablets)",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 219847",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=219847"
   },
   "other": [
    {
     "text": "DailyMed lists a marketing start date of Mar 20, 2026",
     "as_of": "Oct 20, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71cdfc97-96af-4378-a44a-6d5d77e7d6b7"
    }
   ],
   "disagreement": null
  },
  "zenzedi": {
   "name": "Zenzedi",
   "page": "https://adhdmedications.com/zenzedi.html",
   "site_status": "MARKETED",
   "fda_drug_shortages": {
    "text": "No dextroamphetamine immediate-release tablet entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "ANDA 090533",
    "te": [
     "AA"
    ],
    "generics_rx": [
     [
      "Aurolife Pharma LLC",
      "AA"
     ],
     [
      "Avanthi Inc",
      "AA"
     ],
     [
      "Barr Laboratories Inc",
      "AA"
     ],
     [
      "Novel Laboratories Inc",
      "AA"
     ],
     [
      "Nuvo Pharmaceutical Inc",
      "AA"
     ],
     [
      "SpecGx LLC",
      "AA"
     ],
     [
      "Winder Laboratoiries LLC",
      "AA"
     ]
    ],
    "note": "Zenzedi is not listed under its brand name; shown: Azurity's dextroamphetamine sulfate tablets (ANDA).",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=090533"
   },
   "other": [],
   "disagreement": null
  },
  "procentra": {
   "name": "ProCentra",
   "page": "https://adhdmedications.com/procentra.html",
   "site_status": "MARKETED",
   "fda_drug_shortages": {
    "text": "No dextroamphetamine oral solution entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "ANDA 040776",
    "te": [
     "AA"
    ],
    "generics_rx": [
     [
      "Tris Pharma Inc",
      "AA"
     ]
    ],
    "note": "ProCentra is not listed under its brand name; shown: Prasco's dextroamphetamine sulfate oral solution (ANDA).",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=040776"
   },
   "other": [],
   "disagreement": null
  },
  "dexedrine-spansule": {
   "name": "Dexedrine Spansule",
   "page": "https://adhdmedications.com/dexedrine-spansule.html",
   "site_status": "BRAND AVAILABLE (ASHP)",
   "fda_drug_shortages": {
    "text": "No dextroamphetamine ER capsule entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Dexedrine 10 mg available; a Teva generic on back order (release estimated late November 2026)",
    "as_of": "updated Aug 19, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=1167"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 017078",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB"
     ],
     [
      "SpecGx LLC",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=017078"
   },
   "other": [],
   "disagreement": null
  },
  "evekeo-odt": {
   "name": "Evekeo ODT",
   "page": "https://adhdmedications.com/evekeo-odt.html",
   "site_status": "DISCONTINUED",
   "fda_drug_shortages": {
    "text": "No entry for this product",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "DISCN (discontinued)",
    "application": "NDA 209905",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=209905"
   },
   "other": [
    {
     "text": "No current DailyMed label is listed",
     "as_of": "Oct 20, 2026",
     "url": null
    }
   ],
   "disagreement": null
  },
  "desoxyn": {
   "name": "Desoxyn",
   "page": "https://adhdmedications.com/desoxyn.html",
   "site_status": "LISTED RX (ORANGE BOOK)",
   "fda_drug_shortages": {
    "text": "No methamphetamine entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 005378",
    "te": [
     "AA"
    ],
    "generics_rx": [
     [
      "Dr Reddys Laboratories SA",
      "AA"
     ],
     [
      "Hikma Pharmaceuticals USA Inc",
      "AA"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=005378"
   },
   "other": [
    {
     "text": "Wholesaler and pharmacy stock not confirmed",
     "as_of": "Oct 20, 2026",
     "url": null
    }
   ],
   "disagreement": null
  },
  "qelbree": {
   "name": "Qelbree",
   "page": "https://adhdmedications.com/qelbree.html",
   "site_status": "MARKETED",
   "fda_drug_shortages": {
    "text": "No viloxazine entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 211964",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=211964"
   },
   "other": [],
   "disagreement": null
  },
  "strattera": {
   "name": "Strattera (atomoxetine)",
   "page": "https://adhdmedications.com/strattera.html",
   "site_status": "BRAND DISCONTINUED",
   "fda_drug_shortages": {
    "text": "No atomoxetine entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "DISCN (discontinued)",
    "application": "NDA 021411",
    "te": [],
    "generics_rx": [
     [
      "Apotex Inc",
      "AB"
     ],
     [
      "Aurobindo Pharma Ltd",
      "AB"
     ],
     [
      "Dr Reddys Laboratories Ltd",
      "AB"
     ],
     [
      "Glenmark Pharmaceuticals Ltd",
      "AB"
     ],
     [
      "Hetero Labs Ltd Unit V",
      "AB"
     ],
     [
      "Pharmazone",
      "AB"
     ],
     [
      "Strides Pharma Global Pte Ltd",
      "AB"
     ],
     [
      "Teva Pharmaceuticals USA",
      "AB"
     ],
     [
      "Zydus Pharmaceuticals USA Inc",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=021411"
   },
   "other": [],
   "disagreement": null
  },
  "intuniv": {
   "name": "Intuniv",
   "page": "https://adhdmedications.com/intuniv.html",
   "site_status": "",
   "fda_drug_shortages": {
    "text": "Guanfacine ER appears only as a discontinuation (Actavis, 1–4 mg, posted Nov 13, 2025)",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 022037",
    "te": [
     "AB"
    ],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB"
     ],
     [
      "Alembic Pharmaceuticals Ltd",
      "AB"
     ],
     [
      "Apotex Inc",
      "AB"
     ],
     [
      "Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd",
      "AB"
     ],
     [
      "Rubicon Research Ltd",
      "AB"
     ],
     [
      "Sandoz Inc",
      "AB"
     ],
     [
      "Teva Pharmaceuticals USA",
      "AB"
     ],
     [
      "Twi Pharmaceuticals Inc",
      "AB"
     ],
     [
      "Unichem Laboratories Ltd",
      "AB"
     ],
     [
      "Yichang Humanwell Pharmaceutical Co Ltd",
      "AB"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=022037"
   },
   "other": [],
   "disagreement": null
  },
  "kapvay": {
   "name": "Kapvay",
   "page": "https://adhdmedications.com/kapvay.html",
   "site_status": "BRAND DISCONTINUED",
   "fda_drug_shortages": {
    "text": "No clonidine ER tablet entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "DISCN (discontinued)",
    "application": "NDA 022331",
    "te": [],
    "generics_rx": [
     [
      "Actavis Elizabeth LLC",
      "AB1"
     ],
     [
      "Ajanta Pharma Ltd",
      "AB1"
     ],
     [
      "Chartwell Rx Sciences LLC",
      "AB1"
     ],
     [
      "Jubilant Generics Ltd",
      "AB1"
     ],
     [
      "Novast Laboratories Ltd",
      "AB1"
     ],
     [
      "Somerset Therapeutics LLC",
      "AB1"
     ],
     [
      "Xiamen LP Pharmacuetical Co Ltd",
      "AB1"
     ]
    ],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=022331"
   },
   "other": [],
   "disagreement": null
  },
  "onyda-xr": {
   "name": "Onyda XR",
   "page": "https://adhdmedications.com/onyda-xr.html",
   "site_status": "MARKETED",
   "fda_drug_shortages": {
    "text": "No clonidine entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 217645",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=217645"
   },
   "other": [],
   "disagreement": null
  },
  "atoncy": {
   "name": "Atoncy",
   "page": "https://adhdmedications.com/atoncy.html",
   "site_status": "MARKETED (DAILYMED SPL)",
   "fda_drug_shortages": {
    "text": "No atomoxetine entry",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "Not on the current shortage list",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": "RX (active)",
    "application": "NDA 220320",
    "te": [],
    "generics_rx": [],
    "note": "",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=220320"
   },
   "other": [
    {
     "text": "DailyMed lists Atoncy and an authorized generic of the solution as marketed (start Mar 20, 2026)",
     "as_of": "Oct 20, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=72d3d8cf-7f3b-479e-bd9f-e204d4118517"
    }
   ],
   "disagreement": null
  },
  "simtriyo": {
   "name": "Simtriyo",
   "page": "https://adhdmedications.com/simtriyo.html",
   "site_status": "NOW MARKETABLE · CHECK PHARMACY AVAILABILITY",
   "fda_drug_shortages": {
    "text": "No centanafadine entry when checked (before marketing); not rechecked since",
    "as_of": "Oct 20, 2026",
    "url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
   },
   "ashp": {
    "text": "No centanafadine entry when checked (before marketing); not rechecked since",
    "as_of": "Oct 20, 2026",
    "url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortages-list?page=CurrentShortages"
   },
   "orange_book": {
    "brand": null,
    "application": null,
    "te": null,
    "generics_rx": [],
    "note": "Not listed in the October 2026 Orange Book data file (FDA approval became effective Oct 30, 2026, when DEA placed centanafadine in Schedule III; not rechecked since).",
    "as_of": "Orange Book data files, October 2026 (products.txt dated Oct 9, 2026)",
    "url": "https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm"
   },
   "other": [
    {
     "text": "Now marketable: DEA placed centanafadine in Schedule III by an interim final rule published and effective Oct 30, 2026 (91 FR 68470), which made the FDA approval effective. No launch press release found and pharmacy stocking not confirmed; check pharmacy availability",
     "as_of": "Nov 4, 2026",
     "url": "https://www.federalregister.gov/documents/2026/10/30/2026-22208/schedules-of-controlled-substances-placement-of-centanafadine-in-schedule-iii"
    },
    {
     "text": "DailyMed SPL version 1 (published Oct 26, 2026) lists a marketing start date of Oct 24, 2026",
     "as_of": "Nov 4, 2026",
     "url": "https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ecfa41cc-c8c8-419b-8da3-ee5b819398c2"
    }
   ],
   "disagreement": null
  }
 }
}